Page last updated: 2024-09-05

deferasirox and Experimental Leukemia

deferasirox has been researched along with Experimental Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Heath, JL; Lavau, CP; Wechsler, DS; Weiss, JM	1

Other Studies

1 other study(ies) available for deferasirox and Experimental Leukemia

Article	Year
Effects of iron depletion on CALM-AF10 leukemias. Experimental hematology, 2014, Volume: 42, Issue:12 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Biological Transport; Cell Line, Tumor; Chelation Therapy; Combined Modality Therapy; Deferasirox; Deferoxamine; Fibroblasts; Hematopoietic Stem Cells; Heterozygote; Humans; Iron; Iron Chelating Agents; Iron, Dietary; Leukemia, Experimental; Mice; Mice, Knockout; Monomeric Clathrin Assembly Proteins; Oncogene Proteins, Fusion; Radiation Chimera; Spleen; Triazoles; Tumor Burden	2014

Article

Year

Effects of iron depletion on CALM-AF10 leukemias.

Experimental hematology, 2014, Volume: 42, Issue:12

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Biological Transport; Cell Line, Tumor; Chelation Therapy; Combined Modality Therapy; Deferasirox; Deferoxamine; Fibroblasts; Hematopoietic Stem Cells; Heterozygote; Humans; Iron; Iron Chelating Agents; Iron, Dietary; Leukemia, Experimental; Mice; Mice, Knockout; Monomeric Clathrin Assembly Proteins; Oncogene Proteins, Fusion; Radiation Chimera; Spleen; Triazoles; Tumor Burden

2014